About NY Med Pharmaceuticals Pvt.Ltd

NY Med Pharmaceuticals Pvt.Ltd. is an Indian pharmaceutical company incorporated on December 7, 2018, headquartered in Delhi is a private limited company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its founder and current chairman is Mr.M.S.Siddiqui.

NY Med have facilities in India that are cGMP compliant and conform to national and major international standards.

NY Med portfolio includes 200+ products across multiple therapeutic categories, including treatment for acute, chronic and rare conditions. The company makes affordable medicines and has played a pioneering role in chronic therapy treatment.

History of NY MED

NY MED is one of the generic pharmaceutical companies, and has a strong presence in all over india. Its founder and current chairman Mr.M.S.Siddiqui have 30 years of Pharma industries experience and established NY MED in 2018 with the vision to make India self-reliant in healthcare.

NY MED manufacturing facilities in India which are engaged in the manufacture of Active Pharmaceutical Ingredients (APIs) and formulations. These manufacturing facilities have been approved by drug Regulatory Agencies. The company manufactures 200+ products in 12 therapeutic categories and 20+ dosage forms, covering communicable, non-communicable, common and emerging diseases, and rare diseases.

The primary focus of NY Med is Research and Development (R&D) center is to develop innovative and affordable products and drug delivery systems.